Hand over computer screen

Prof. Dr. Beat Lutz

Scientific Managing Director LIR, Professor and Director of Institute of Physiological Chemistry University Medical Center of the Johannes Gutenberg-University Mainz

Kontakt

Leibniz-Institut für Resilienzforschung gGmbH
Wallstraße 7
55122 Mainz

+49 (0)6131 89448-37


Sekretariat (8:30 - 15:00)
E-Mail: verena.huber@lir-mainz.de
Telefon: +49 (0)6131 89448-77

Expertise

Behavioral Genetics in mouse. Mechanisms underlying learning and memory, and stress coping. Epigenetic mechanisms underlying behavior. Lipid signaling systems (mainly on endocannabinoids and cannabinoid receptors). Roles of the endocannabinoid system in anxiety, fear memory, stress coping, synaptic plasticity, adult neurogenesis, neural development, and energy metabolism.

General Information
Year of Birth

1961

Current Position

Scientific Managing Director and Research Group Leader Leibniz Institute for Resilience Research (LIR), Mainz, Germany

Professor and Director at Institute of Physiological Chemistry, University Medical Center of the Johannes Gutenberg-University Mainz

University training and degrees
1/2002

Habilitation in Zoology at the LMU Munich, Germany (Prof. G. Neuweiler)

10/1990

Diploma for Gymnasium teacher in Chemistry, ETH, Switzerland

3/1989

Dr. sc. nat: ETH Zurich Switzerland

6/1985-03/1989

Doctorate work at the Institute for Cell Biology, ETH Zurich, Switzerland (Prof. M. Lezzi, Prof. H. Eppenberger)

5/1985

Diploma in Natural Sciences at ETH Zurich, Switzerland

9/1980-05/1985

Studies in Biochemistry at ETH Zurich, Switzerland

Advanced academic qualifications
1/2002

Habilitation in Zoology at the LMU Munich, Germany (Prof. G. Neuweiler)

Postgraduate professional career
Since 1/2020

Scientific Managing Director and Research Group Leader, Leibniz Institute for Resilience Research (LIR), Mainz, German

Since 1/2009

Director of the Institute of Physiological Chemistry, University Medical Center of the Johannes Gutenberg University, Mainz, Germany

Since 10/2004

W3 Professor for Physiological Chemistry, Institute of Physiological Chemistry and Pathobiochemistry, Johannes Gutenberg University, Mainz, Germany

04/1997 – 09/2004

Independent Group Leader of the Max Planck Society at the Max Planck Institute of Psychiatry, Munich, Germany

04/1995 – 03/1997

Scientist at the DKFZ, Heidelberg, Germany (Prof. G. Schütz)

04/1989 – 03/1995

Postdoctoral positions at ETH Zurich, Switzerland (Prof. M. Lezzi), Harvard Medical School, Boston, MA USA (Prof. G. Eichele), and Baylor College of Medicine, Houston, TX, USA (Prof. G. Eichele)

 

Other professional activities or honors
2016-2020

Spokesperson of the CRC1193 „Neurobiology of Resilience“

Since 2016

Tenure Commission at UM Mainz, Germany

Since 2015

Co-organizer of the International Symposium on Resilience Research

2014-2019

Member of Fachbereichsrat at UM Mainz, Germany

2014

Mechoulam Award for Outstanding Contributions to Cannabinoid Research

2011

Chair of the Gordon Research Conference “Cannabinoid Functions in the CNS”

2008 – 2014

Spokesperson of DFG Research Unit FOR926 (with A. Zimmer, Bonn, Germany)

2003 – 2004

Stipend from the Hertie Foundation (Excellence Program in Neurosciences)

2002

Organon Prize for Psychiatry

1990 – 1994

Fellowships from the Swiss National Foundation

 

Transparenz / Erklärung von Interessen

Herr Professor Dr. Beat Lutz ist seit 2004 Professor für physiologische Chemie an der Universitätsmedizin Mainz, dort Direktor des Instituts für Physiologische Chemie und seit 2020 wissenschaftlicher Direktor und Arbeitsgruppenleiter am Leibniz-Institut für Resilienzforschung. Er hat seit 2018 keine persönlichen Honorare für Beratertätigkeiten, Fortbildungsveranstaltungen, Vorträge oder Stellungnahmen von pharmazeutischen Unternehmen oder Medizinprodukteherstellern erhalten. Von der gemeinnützigen Boehringer Ingelheim Stiftung erhielt Prof. Lutz zusammen mit anderen Wissenschaftlerinnen und Wissenschaftlern Forschungsmittel für die Jahre 2017-2020 zum Aufbau des Leibniz-Instituts für Resilienzforschung.

Selected Publications

Martin-Garcia E, Domingo-Rodriguez L, Lutz B, Maldonado R, Ruiz de Azua I (2025) Cannabinoid type-1 receptors in CaMKII neurons drive impulsivity in pathological eating behavior. Mol Metab. 92:102096. doi:10.1016/j.molmet.2025.102096

>> Link zu Pubmed

Pastore S, Hillenbrand P, Molnar N, Kovlyagina I, Chongtham MC, Sys S, Lutz B, Tevosian M, Gerber S (2025) ClearFinder: a Python GUI for annotating cells in cleared mouse brain. BMC Bioinformatics. 26(1):24. doi:10.1186/s12859-025-06039-x

>> Link zu Pubmed

Kovlyagina I, Wierczeiko A, Todorov H, Jacobi E, Tevosian M, von Engelhardt J, Gerber S, Lutz B. Leveraging interindividual variability in threat conditioning of inbred mice to model trait anxiety (2024) PLoS Biol. 22(5):e3002642. doi:10.1371/journal.pbio.3002642

>> Link zu Pubmed

Monory K, Ruiz de Azua I, Lutz B (2024) Genetic tools in rodents to study cannabinoid functions. Curr Top Behav Neurosci. doi:10.1007/7854_2024_550

>> Link zu Pubmed

Tevosian M, Todorov H, Lomazzo E, Bindila L, Ueda N, Bassetti D, Warm D, Kirischuk S, Luhmann HJ, Gerber S, Lutz B (2023) NAPE-PLD deletion in stress-TRAPed neurons results in an anxiogenic phenotype. Transl Psychiatry. 13(1):152. doi:10.1038/s41398-023-02448-9

>> Link zu Pubmed

Busch AM, Kovlyagina I, Lutz B, Todorov H, Gerber S (2022) beeRapp: an R shiny app for automated high-throughput explorative analysis of multivariate behavioral data. Bioinform Adv. 2(1):vbac082. doi:10.1093/bioadv/vbac082

>> Link zu Pubmed

Leschik J, Gentile A, Cicek C, Péron S, Tevosian M, Beer A, Radyushkin K, Bludau A, Ebner K, Neumann I, Singewald N, Berninger B, Lessmann V, Lutz B (2022) Brain-derived neurotrophic factor expression in serotonergic neurons improves stress resilience and promotes adult hippocampal neurogenesis. Prog Neurobiol. 217:102333. doi:10.1016/j.pneurobio.2022.102333

>> Link zu Pubmed

Pascual Cuadrado D, Todorov H, Lerner R, Islami L, Bindila L, Gerber S, Lutz B (2022) Long-term molecular differences between resilient and susceptible mice after a single traumatic exposure. Br J Pharmacol. 179(17):4161–4180. doi:10.1111/bph.15697

>> Link zu Pubmed

Vennin C, Hewel C, Todorov H, Wendelmuth M, Radyushkin K, Heimbach A, Horenko I, Ayash S, Müller MB, Schweiger S, Gerber S, Lutz B (2022) A resilience related glial-neurovascular network is transcriptionally activated after chronic social defeat in male mice. Cells. 11(21):3405. doi:10.3390/cells11213405

>> Link zu Pubmed

Leschik J, Lutz B, Gentile A (2021) Stress-related dysfunction of adult hippocampal neurogenesis—an attempt for understanding resilience? Int J Mol Sci. 22(14):7339. doi:10.3390/ijms22147339

>> Link zu Pubmed

Navandar M, Martín-García E, Maldonado R, Lutz B, Gerber S, Ruiz de Azua I (2021) Transcriptional signatures in prefrontal cortex confer vulnerability versus resilience to food and cocaine addiction-like behavior. Sci Rep. 11(1):9076. doi:10.1038/s41598-021-88363-9

>> Link zu Pubmed

Domingo-Rodriguez L, Ruiz de Azua I, Dominguez E, Senabre E, Serra I, Kummer S, Navandar M, Baddenhausen S, Hofmann C, Andero R, Gerber S, Navarrete M, Dierssen M, Lutz B, Martín-García E, Maldonado R (2020) A specific prelimbic-nucleus accumbens pathway controls resilience versus vulnerability to food addiction. Nat Commun. 11(1):782. doi:10.1038/s41467-020-14458-y

>> Link zu Pubmed

Lutz B (2020) Neurobiology of cannabinoid receptor signaling. Dialogues Clin Neurosci. 22(3):207–22. doi:10.31887/DCNS.2020.22.3/blutz

>> Link zu Pubmed
Cookie-Einstellungen:
Sie können Ihre Cookie-Einstellungen jederzeit im Footer dieser Website ändern.